Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report

We report on the significant improvement of central macular thickness in a case of clinically significant macular edema after dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex®; Allergan, Inc, Irvine, CA, USA). Patient presented to us with persistent clinically significant macular...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Ashish, Madhusudhan, Rangasamy J, Nadahalli, Vidhya, Damgude, Shreekant A, Sundaramoorthy, Selva K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361827/
https://www.ncbi.nlm.nih.gov/pubmed/22569393
http://dx.doi.org/10.4103/0301-4738.95884
_version_ 1782234158310883328
author Sharma, Ashish
Madhusudhan, Rangasamy J
Nadahalli, Vidhya
Damgude, Shreekant A
Sundaramoorthy, Selva K
author_facet Sharma, Ashish
Madhusudhan, Rangasamy J
Nadahalli, Vidhya
Damgude, Shreekant A
Sundaramoorthy, Selva K
author_sort Sharma, Ashish
collection PubMed
description We report on the significant improvement of central macular thickness in a case of clinically significant macular edema after dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex®; Allergan, Inc, Irvine, CA, USA). Patient presented to us with persistent clinically significant macular edema (CSME) in both eyes. Right eye received dexamethasone implant and left eye received two intravitreal bevacizumab injections 1.25 mg/0.05 mL (Avastin®; Genentech Inc., South San Francisco, CA, USA) with an interval of four weeks. After six weeks of follow-up, dexamethasone implant in the right eye showed normal macular thickness whereas persistent macular edema (ME) was found even after second intravitreal bevacizumab injection in the left eye.
format Online
Article
Text
id pubmed-3361827
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33618272012-06-01 Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report Sharma, Ashish Madhusudhan, Rangasamy J Nadahalli, Vidhya Damgude, Shreekant A Sundaramoorthy, Selva K Indian J Ophthalmol Brief Communications We report on the significant improvement of central macular thickness in a case of clinically significant macular edema after dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex®; Allergan, Inc, Irvine, CA, USA). Patient presented to us with persistent clinically significant macular edema (CSME) in both eyes. Right eye received dexamethasone implant and left eye received two intravitreal bevacizumab injections 1.25 mg/0.05 mL (Avastin®; Genentech Inc., South San Francisco, CA, USA) with an interval of four weeks. After six weeks of follow-up, dexamethasone implant in the right eye showed normal macular thickness whereas persistent macular edema (ME) was found even after second intravitreal bevacizumab injection in the left eye. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3361827/ /pubmed/22569393 http://dx.doi.org/10.4103/0301-4738.95884 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communications
Sharma, Ashish
Madhusudhan, Rangasamy J
Nadahalli, Vidhya
Damgude, Shreekant A
Sundaramoorthy, Selva K
Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
title Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
title_full Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
title_fullStr Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
title_full_unstemmed Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
title_short Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
title_sort change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: a case report
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361827/
https://www.ncbi.nlm.nih.gov/pubmed/22569393
http://dx.doi.org/10.4103/0301-4738.95884
work_keys_str_mv AT sharmaashish changeinmacularthicknessinacaseofrefractorydiabeticmacularedemawithdexamethasoneintravitrealimplantincomparisontointravitrealbevacizumabacasereport
AT madhusudhanrangasamyj changeinmacularthicknessinacaseofrefractorydiabeticmacularedemawithdexamethasoneintravitrealimplantincomparisontointravitrealbevacizumabacasereport
AT nadahallividhya changeinmacularthicknessinacaseofrefractorydiabeticmacularedemawithdexamethasoneintravitrealimplantincomparisontointravitrealbevacizumabacasereport
AT damgudeshreekanta changeinmacularthicknessinacaseofrefractorydiabeticmacularedemawithdexamethasoneintravitrealimplantincomparisontointravitrealbevacizumabacasereport
AT sundaramoorthyselvak changeinmacularthicknessinacaseofrefractorydiabeticmacularedemawithdexamethasoneintravitrealimplantincomparisontointravitrealbevacizumabacasereport

Ejemplares similares